These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8111834)
21. Pyrimidines as the chemotherapeutic drugs. Cieplik J; Królicki ZA Acta Pol Pharm; 1992; 49(4):59-66. PubMed ID: 16092437 [TBL] [Abstract][Full Text] [Related]
22. Current status of new drugs for the treatment of patients with multiple myeloma. Kenealy M; Prince HM Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741 [TBL] [Abstract][Full Text] [Related]
23. [Calcium antagonists as amplifiers of the mutagenicity of cytostatic drugs]. Scheid W; Traut H Wien Med Wochenschr; 1993; 143(19-20):522-6. PubMed ID: 8135036 [TBL] [Abstract][Full Text] [Related]
24. [The interactions of antiepileptic drugs in oncology practice]. Armijo JA; Sánchez MB; Campos C; Adín J Rev Neurol; 2006 Jun 1-15; 42(11):681-90. PubMed ID: 16736404 [TBL] [Abstract][Full Text] [Related]
25. Economics of new oncology drug development. DiMasi JA; Grabowski HG J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942 [TBL] [Abstract][Full Text] [Related]
26. New antiretrovirals and new combinations. Havlir DV; Lange JM AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999 [TBL] [Abstract][Full Text] [Related]
27. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
28. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Low PS; Henne WA; Doorneweerd DD Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275 [TBL] [Abstract][Full Text] [Related]
29. Sulindac and its derivatives: a novel class of anticancer agents. Haanen C Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947 [TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of new quinolones as antituberculosis drugs]. Kawahara S; Tada A; Nagare H Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058 [TBL] [Abstract][Full Text] [Related]
31. Experimental evidence for killing the resistant cells and raising the efficacy and decreasing the toxicity of cytostatics and irradiation by mixtures of the agents of the passive antitumor defense system in the case of various tumor and normal cell lines in vitro. Kulcsár G Cancer Biother Radiopharm; 2009 Feb; 24(1):67-80. PubMed ID: 19243249 [TBL] [Abstract][Full Text] [Related]
32. Anaesthesia and new antithrombotic drugs. Vandermeulen E Curr Opin Anaesthesiol; 2005 Jun; 18(3):353-9. PubMed ID: 16534362 [TBL] [Abstract][Full Text] [Related]
33. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise]. Ekimoto H Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
38. [Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation]. Ishioka S Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():432-8. PubMed ID: 9369919 [TBL] [Abstract][Full Text] [Related]
39. Drug research: from the idea to the product. Kuhlmann J Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711 [TBL] [Abstract][Full Text] [Related]
40. [The present-day use of cytostatics in clinical and general practice]. Moeschlin S Med Klin; 1965 Jul; 60(30):1185-91. PubMed ID: 5320801 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]